 |
|
|
REFERENCES
151.
Prody CA, Dreyfus P, Zamir R, et al: De novo
amplification within a "silent" human cholinesterase gene in a family subjected to
prolonged exposure to organophosphorus insecticides. Proc Natl Acad Sci U S A 86:690,
1989.
152.
Sussman JL, Harel M, Frolow F, et al: Atomic
structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding
protein. Science 253:872, 1991.
153.
Tassonyi E, Charpantier E, Muller D, et al: The
role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain
Res Bull 57:133, 2002.
154.
Smit AB, Syed NI, Schaap D, et al: A glia-derived
acetylcholine-binding protein that modulates synaptic transmission. Nature 411:261,
2001.
155.
Martinou J-C, Falls DL, Fischbach GD, et al:
Acetylcholine receptor-inducing activity stimulates expression of the epsilon-subunit
gene of the muscle acetylcholine receptor. Proc Natl Acad Sci U S A 87:7669, 1991.
156.
McMahan UJ, Horton SE, Werle MJ, et al: Agrin
isoforms and their role in synaptogenesis. Curr Opin Cell Biol 4:869, 1992.
157.
Nastuk MA, Fallon JR: Agrin and the molecular
choreography of synapse formation. Trends Neurosci 16:72, 1993.
158.
Apel ED, Merlie JP: Assembly of the postsynaptic
apparatus. Curr Opin Neurobiol 5:62, 1995.
159.
Eglen RM, Hedge SS, Watson N: Muscarinic receptor
subtypes and smooth muscle function. Pharmacol Rev 48:531, 1996.
160.
Hosey MM: Diversity of structure, signaling and
regulation within the family of muscarinic cholinergic receptors. FASEB J 12:845,
1992.
161.
Ganong W: The autonomic nervous system. In
Ganong W (ed): Review of Medical Physiology, 15th ed. Norwalk, CT, Appleton &
Lange, 1991, p 210.
162.
Glusman S: Electrophysiology of ganglionic transmission
in the sympathetic nervous system. Int Anesthesiol Clin 27:273, 1989.
163.
Hoffman BB, Lefkowitz RJ: Catecholamines and
sympathetic drugs. In Goodman A, Rall T, Nies A,
et al (eds): Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th
ed. New York, Pergamon Press, 1990, p 187.
164.
Paradis NA, Martin GB, Rivers EP, et al: Coronary
perfusion pressure and the return of spontaneous circulation in human cardiopulmonary
resuscitation. JAMA 263:1106, 1990.
165.
Emergency Cardiac Care Committee: Guidelines
for cardiopulmonary resuscitation and emergency cardiac care. III. Adult advanced
cardiac life support. JAMA 268:2199, 1992.
166.
Emergency Cardiac Care Committee: Guidelines
for cardiopulmonary resuscitation and emergency cardiac care. VI. Pediatric advanced
life support. JAMA 268:2262, 1992.
167.
Goetting M, Paradis N: High-dose epinephrine
improves outcome from pediatric cardiac arrest. Ann Emerg Med 20:22, 1991.
168.
Aitkenhead A: Drug administration during CPR:
What route? Resuscitation 22:191, 1991.
169.
Berry F: Clinical pharmacology of inhalational
anesthetic, muscle relaxants, vasoactive agents, and narcotics, and techniques of
general anesthesia. In Berry F (ed): Anesthetic
Management of Difficult and Routine Pediatric Patients, 2nd ed. New York, Churchill
Livingstone, 1990, p 64.
170.
Ziment I: Pharmacology of sympathomimetic agents.
In Ziment I (ed): Respiratory Pharmacology and
Therapeutics. Philadelphia, WB Saunders, 1978.
171.
Waisman Y, Klein BL, Boenning DA, et al: Prospective
randomized double blind study comparing L-epinephrine
and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup).
Pediatrics 89:302, 1992.
172.
Nutman J, Brooks LJ, Deakins KM, et al: Racemic
versus L-epinephrine aerosol in the treatment of
postextubation laryngeal edema: Results from a prospective, randomized double-blind
study. Crit Care Med 22:1591, 1994.
173.
Bochner BS, Lichtenstein L: Anaphylaxis. N Engl
J Med 324:1785, 1991.
174.
Donlon J, Moss J: Plasma catecholamine levels
during local anesthesia for cataract operations. Anesthesiology 51:471, 1979.
175.
Houben H, Thien T, van't Laar A: Effect of low-dose
epinephrine on hemodynamics after selective and nonselective beta-blockade in hypertension.
Clin Pharmacol Ther 31:685, 1982.
176.
Johnston R, Eger E, Wilson C: A comparative interaction
of epinephrine with enflurane, isoflurane, and halothane in man. Anesth Analg 55:709,
1976.
177.
Zaritsky A, Chernow B: Catecholamines, sympathomimetics.
In Chernow B, Lake C (eds): The Pharmacologic Approach
to the Critically Ill Patient. Baltimore, Williams & Wilkins, 1983, p 481.
178.
O'Neill MJ Jr, Pennock JL, Seaton JF, et al:
Regional endogenous plasma catecholamine concentrations in pulmonary hypertension.
Surgery 84:140, 1978.
179.
Benowitz N, Forsyth RP, Melman KL, et al: Lidocaine
disposition kinetics in monkey and man: Effects of hemorrhage and sympathomimetic
drug administration. Clin Pharmacol Ther 16:19, 1974.
180.
Schafer G, Fink M, Parillo J: Norepinephrine
alone versus norepinephrine plus low dose dopamine: Enhanced renal blood flow with
combination pressor therapy. Crit Care Med 13:492, 1985.
181.
Goldberg L: Dopamine: Clinical uses of an endogenous
catecholamine. N Engl J Med 291:707, 1974.
182.
Goldberg LI, Hsieh Y-Y, Resnekov L: Newer catecholamines
for treatment of heart failure and shock: An update on dopamine and a first look
at dobutamine. Prog Cardiovasc Dis 19:327, 1977.
183.
Maskin C, Ocken S, Chadwick B, et al: Comparative
systemic and renal effects of dopamine and angiotensin-converting enzyme inhibitor
with enalapril in patients with heart failure. Circulation 72:846, 1985.
184.
Richard C, Ricome J, Rimailho A, et al: Combined
hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation
67:620, 1983.
185.
Brown RA, Dixon J, Farmer JB, et al: Dopexamine:
A novel agonist at peripheral dopamine receptors and β2-adrenoceptors. Br
J Pharmacol 85:599, 1985.
186.
Foulds RA: Clinical development of dopexamine
hydrochloride (Dopacard) and an overview of its hemodynamic effects. Am J Cardiol
62:41C, 1988.
187.
Smith GW, O'Connor SE: An introduction to the
pharmacologic properties of Dopacard (dopexamine hydrochloride). Am J Cardiol 62:9C,
1988.
188.
Fitton A, Benfield P: Dopexamine hydrochloride:
A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
in acute cardiac insufficiency. Drugs 39:308, 1990.
189.
Smith GW, Hall JC, Farmer JB, et al: The cardiovascular
actions of dopexamine hydrochloride, an agonist at dopamine receptors and β2-adrenoceptors
in the dog. J Pharm Pharmacol 39:636, 1987.
190.
Mitchell PD, Smith GW, Wells E, et al: Inhibition
of uptake 1 by dopexamine hydrochloride in vitro. Br J Pharmacol 92:265, 1987.
191.
Lokhandwala MF: Renal actions of dopexamine hydrochloride.
Clin Intensive Care 1:163, 1990.
192.
Vyas SJ, Lokhandwala MF: Role of tubular dopamine-1
receptors in the natriuretic and diuretic response to dopexamine. Pharmacologist
31:378, 1989.
193.
Bass AS: Contrasting effects of dopexamine hydrochloride
on electrolyte excretion in canine kidneys. J Pharmacol Exp Ther 253:798, 1990.
194.
Chintala MS, Lokhandwala MF, Jandhyala BS: Protective
effects of dopexamine hydrochloride in renal failure after acute hemorrhage in anesthetized
dogs. J Auton Pharmacol 10(Suppl):S95, 1990.
195.
Leier CV, Binkley PF, Carpenter J, et al: Cardiovascular
pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol
62:94, 1988.
196.
Baumann G, Felix SB, Filcek SAL: Usefulness of
dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and
the effects on hemodynamics and urine output. Am J Cardiol 65:748, 1990.
197.
Colardyn FC, Vandenbogaerde FE: Use of dopexamine
hydrochloride in intensive care patients with low-output left ventricular heart failure.
Am J Cardiol 62:68C, 1988.
198.
Friedel N, Wenzel R, Matheis G, et al: Haemodynamic
effects of different doses of dopexamine hydrochloride in low cardiac output states
following cardiac surgery. Eur Heart J 13:1271, 1992.
199.
Bredle DL, Cain SM: Systemic and muscle oxygen
uptake delivery after dopexamine infusion in endotoxic dogs. Crit Care Med 19:198,
1991.
200.
Cain SM, Curtis SE: Systemic and regional oxygen
uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine.
Crit Care Med 19:1552, 1991.
201.
Colardyn FC, Vandenbogaerde JF, Vogelaers DP,
et al: Use of dopexamine hydrochloride in patients with septic shock. Crit Care
Med 17:999, 1989.
202.
Preiser JC, Arminstead C, Le Minh T, et al: Increase
in oxygen supply during experimental septic shock: The effects of dobutamine versus
dopexamine. J Crit Care 4:40, 1989.
203.
Webb AR, Moss RF, Tighe D, et al: The effects
of dobutamine, dopexamine and fluid on hepatic histological response to porcine faecal
peritonitis. Intensive Care Med 17:487, 1991.
204.
Hakim M, Foulds R, Latimer RD, et al: Dopexamine
hydrochloride, a β2-adrenergic and dopaminergic agonist: Haemodynamic effects
following cardiac surgery. Eur Heart J 9:853, 1988.
205.
Macgregor DA, Butterworth JF IV, Zaloga GP, et
al: Hemodynamic and renal effects of dopexamine and doubtamine in patients with
reduced cardiac output following coronary artery bypass grafting. Chest 106:835,
1994.
206.
Smithies M, Yee TH, Jackson L, et al: Protecting
the gut and the liver in the critically ill: Effects of dopexamine. Crit Care Med
22:789, 1994.
207.
Lund N, de Asla RJ, Papadakos PJ, et al: Dopexamine
hydrochloride in septicemia: Effects on gut, liver and muscle oxygenation [abstract].
Crit Care Med 20(Suppl 4):46, 1992.
208.
Trinder TJ, Lavery GG, Fee JPH, et al: Correction
of splanchnic oxygen deficit in the intensive care unit: Dopexamine and colloid
versus placebo. Anaesth Intensive Care 23:178, 1995.
209.
Kuhly P, Oschmann G, Specht M, et al: Dopexamine
hydrochloride does not improve gastric and sigmoid mucosal acidosis in patients with
sepsis [abstract]. Br J Anesth 74(Suppl 1):121, 1995.
210.
Schmidt H, Secchi A, Wellmann R, et al: Dopexamine
maintains intestinal villus blood flow during endotoxemia in rats. Crit Care Med
24:1233, 1996.
211.
Maynard N, Bihari D, Dalton RN, et al: Increasing
splanchnic blood flow in the critically ill. Chest 108:1648, 1995.
212.
Jackson NC, Taylor SH, Frais MA: Hemodynamic
comparison of dopexamine hydrochloride and dopamine in ischemic left ventricular
dysfunction. Am J Cardiol 62:73, 1988.
213.
Tan LB, Littler WA, Murray RG: Comparison of
the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive
heart failure. Int J Cardiol 30:203, 1991.
214.
Young JB, Leon CA: Fenoldopam. In
Messerli FH (ed): Cardiovascular Drug Therapy. Philadelphia, WB Saunders, 1990.
215.
Lokhandwala MF: Pre-clinical and clinical studies
on the cardiovascular and renal effects of fenoldopam: A DA-1 receptor agonist.
Drug Dev Res 10:123, 1987.
216.
Goldberg LI: Dopamine and new dopamine analogs:
Receptors and clinical applications. J Clin Anesth 1:66, 1988.
217.
Aronson S, Goldberg L, Roth S, et al: Preservation
of renal blood flow during hypotension induced with fenoldopam in dogs. Can J Anaesth
37:380, 1990.
218.
Aronson S, Goldberg LI, Roth S, et al: Effects
of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia
in dogs. J Cardiothorac Vasc Anesth 5:29, 1991.
219.
Shusterman NH, Elliott WJ, White WB: Fenoldopam,
but not nitroprusside, improves renal function in severely hypertensive patients
with impaired renal function. Am J Med 95:161, 1993.
220.
Pilmer BL, Green JA, Panacek EA, et al: Fenoldopam
mesylate versus sodium nitroprusside in the acute management of severe system hypertension.
J Clin Pharmacol 33:549, 1993.
221.
Shnider S, Levinson G, Cosmi E: Obstetric anesthesia
and uterine blood flow. In Schnider S, Levinson
G (eds): Anesthesia for Obstetrics, 3rd ed. Baltimore, Williams & Wilkins,
1993, p 29.
222.
Caplan R, Ward R, Posner K, Cheney F: Unexpected
cardiac arrest during spinal anesthesia: A closed claims analysis of predisposing
factors. Anesthesiology 68:5, 1988.
223.
Shibata S, Seriguchi DG, Iwadare S, et al: The
regional and species differences on the activation of myocardial α-adrenoreceptors
by phenylephrine and methoxamine. Gen Pharmacol 11:173, 1980.
224.
DeVos H, Bricca G, DeKeyser J, et al: Imidazoline
receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the
human central nervous system. Neuroscience 59:589, 1994.
225.
Hamilton CA: The role of imidazoline receptors
in blood pressure regulation. Pharmacol Ther 54:231, 1992.
226.
Guyenet PG, Cabot JB: Inhibition of sympathetic
preganglionic neurons by catecholamines and clonidine: Mediation by an α-adrenergic
receptor. J Neurosci 1:908, 1981.
227.
Ruffolo RR Jr: Distribution and function of peripheral
α-adrenoceptors on the cardiovascular system. Pharmacol Biochem Behav 22:827,
1985.
228.
Muzi M, Goff D, Kampine J, et al: Clonidine reduces
sympathetic activity but maintains baroreflex responses in normotensive humans.
Anesthesiology 77:864, 1992.
229.
Aho M, Erkola O, Korttila K: α2-Adrenergic
agonists in anaesthesia. Curr Opin Anesthesiol 5:481, 1992.
230.
Flacke J, Bloor BC, Flacke WE, et al: Reduced
narcotic requirement by clonidine with improved hemodynamic and adrenergic stability
in patients undergoing coronary bypass surgery. Anesthesiology 67:11, 1987.
231.
Ghignone M, Quintin L, Duke P, et al: Effects
of clonidine on narcotic requirements and hemodynamic response during induction of
fentanyl anesthesia and endotracheal intubation. Anesthesiology 64:36, 1986.
232.
Maze M, Tranguilli W: α2-Adrenoreceptor
agonists: Defining the role in clinical anesthesia. Anesthesiology 74:581, 1991.
233.
Bloor BC, Flacke WE: Reduction in halothane anesthetic
requirement by clonidine, an α2 adrenergic agonist. Anesth Analg 61:741, 1982.
234.
Ghignone M, Calvillo O, Quintin L: Anesthesia
and hypertension: The effect of clonidine on perioperative hemodynamics and isoflurane
requirements. Anesthesiology 67:3, 1987.
235.
Orko R, Pouttu J, Ghignone M: Effect of clonidine
on hemodynamic responses to endotracheal intubation and gastric acidity. Acta Anaesthesiol
Scand 31:325, 1987.
236.
Aantaa R, Jaakola ML, Kallio A, et al: A comparison
of dexmedetomidine, an α2-adrenoceptor agonist, and midazolam as i.m. premedication
for minor gynaecological surgery. Br J Anaesth 67:402, 1991.
237.
Aantaa RE, Kanto JH, Scheinin M: Dexmedetomidine
premedication for minor gynecologic surgery. Anesth Analg 70:407, 1990.
238.
Aantaa RE, Kanto JH, Scheinin M: Dexmedetomidine,
an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing
minor gynecologic surgery. Anesthesiology 73:230, 1990.
239.
Richards MJ, Skues MA, Jarvis AP, Prys-Roberts
C: Total i.v. anaesthesia with propofol and alfentanil: Dose requirements for propranolol
and the effect of premedication with clonidine. Br J Anaesth 65:157, 1990.
240.
Bonnet F, Brun-Buisson V, Saada M: Dose-related
prolongation of hyperbaric tetracaine spinal anesthesia by clonidine in humans.
Anesth Analg 68:619, 1989.
241.
Murga G, Samso E, Valles J, et al: The effect
of clonidine on intra-operative requirements of fentanyl during combined epidural/general
anesthesia. Anaesthesia 49:999, 1994.
242.
Klimscha W, Chiari A, Drafft P, et al: Hemodynamic
and analgesic effects of clonidine added repetitively to continuous epidural and
spinal blocks. Anesth Analg 80:322, 1995.
243.
Delaunay L, Leppert C, Dechaubry V, et al: Epidural
clonidine decreases postoperative requirements for epidural fentanyl. Reg Anesth
18:176, 1993.
244.
Bonnet F, Diallo A, Saada M, et al: Prevention
of tourniquet pain by spinal isobaric bupivacaine with clonidine. Br J Anaesth 63:93,
1989.
245.
Racle JP, Benkhadra A, Poy JY, Bleizal B: Prolongation
of isobaric bupivacaine spinal anesthesia with epinephrine and clonidine for hip
surgery in the elderly. Anesth Analg 66:442, 1987.
246.
Bonnet F, Catoire P, Brun-Buison V, et al: Effects
of oral and subarachnoid clonidine on spinal anesthesia with bupivacaine. Reg Anesth
15:211, 1990.
247.
Fogarty DJ, Carabine UA, Milligan KR: Comparison
of the analgesic effects of intrathecal clonidine and intrathecal morphine after
spinal anesthesia in patients undergoing total hip replacement. Br J Anaesth 71:661,
1993.
248.
Niemi L: Effects of intrathecal clonidine on
duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia
in patients undergoing knee arthroscopy. Acta Anaesthesiol Scand 38:724, 1994.
249.
Fukuda T, Dohi S, Naito H: Comparisons of tetracaine
spinal anesthesia with clonidine or phenylephrine in normotensive and hypertensive
humans. Anesth Analg 78:106, 1994.
250.
Singelyn FJ, Dangoisse M, Bartholomee S, Gouverneur
JM: Adding clonidine to mepivacaine prolongs the duration of anesthesia and analgesia
after axillary brachial plexus block. Reg Anesth 17:148, 1992.
251.
Macaire P, Bernard JM, LeRoux D, et al: Dose-ranging
study of clonidine added to lidocaine for axillary plexus block in outpatients [abstract].
Anesthesiology 83:A774, 1995.
252.
Singelyn FJ, Muller G, Gouverneur JM: Adding
fentanyl and clonidine to mepivacaine results in a rapid onset and prolonged anesthesia
and analgesia after brachial plexus blockade [abstract]. Anesthesiology 75:A653,
1991.
253.
Bartholomee S, Singelyn FJ, Broka S, Gouverneur
JM: Clonidine added to mepivacaine for brachial plexus blockade: Its minimal effective
dose prolonging the duration of both anesthesia and analgesia [abstract]. Anesthesiology
75:A1084, 1991.
254.
Tschernko E, Benditte H, Kritzinger M, et al:
Clonidine added to the anesthetic solution prolongs analgesia and improves arterial
oxygen tension after intercostal nerve blockade [abstract]. Anesthesiology 83:A846,
1995.
255.
Breslow MJ: The role of stress hormones in perioperative
myocardial ischemia. Int Anesthesiol Clin 30:81, 1992.
256.
Ghignone MC, Cavillo O, Quintin L: Anesthesia
for ophthalmic surgery in the elderly: The effects of clonidine on intraocular pressure,
perioperative hemodynamics, and anesthesia requirement. Anesthesiology 68:707, 1988.
257.
Jaakola ML, Ali-Melkkila T, Kanto J: Dexmedetomidine
reduces intraocular pressure, intubation responses and anaesthetic requirements in
patients undergoing ophthalmic surgery. Br J Anaesth 68:570, 1992.
258.
Kumar A, Bose S, Phattacharya A: Oral clonidine
premedication for elderly patients undergoing intraocular surgery. Acta Anaesthesiol
Scand 36:159, 1992.
259.
Ebert TJ, Hall JE, Barney JA, et al: The effects
of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology
93:382, 2000.
260.
Arain SR, Ebert TJ: The efficacy, side effects,
and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative
sedation. Anesth Analg 95:461, 2002.
261.
Segal IS, Vickery RG, Walton JK: Dexmedetomidine
diminishes halothane anesthetic requirements in rats through a postsynaptic α2-adrenergic
receptor. Anesthesiology 69:818, 1988.
262.
Vickery RG, Sheridan BS, Segal IS, Maze M: Anesthetic
and hemodynamic effects of the stereoisomers of medetomidine, an α2-adrenergic
agonist, in halothane-anesthetized dogs. Anesth Analg 67:611, 1988.
263.
Talke P, Chen R, Thomas B, et al: The hemodynamic
and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery.
Anesth Analg 90:834, 2000.
264.
Peden CJ, Cloote AH, Stratford N, et al: The
effect of intravenous dexmedetomidine premedication on the dose requirement of propofol
to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 56:408,
2001.
265.
Triltsch AE, Welte M, von Homeyer P, et al: Bispectral
index-guided sedation with dexmedetomidine in intensive care: A prospective, randomized,
double blind, placebo-controlled phase II study. Crit Care Med 30:1007, 2002.
266.
DeKock M, Pichon G, Scholtes JL: Intraoperative
clonidine enhances postoperative morphine patient-controlled analgesia. Can J Anaesth
39:537, 1992.
267.
Motsh J, Graber E, Ludwig K: Addition of clonidine
enhances postoperative analgesia from epidural morphine: A double blind study.
Anesthesiology 73:1066, 1990.
268.
Bernard JM, Hommeril JL, Passuti N, Pinaud M:
Postoperative analgesia by intravenous clonidine. Anesthesiology 75:577, 1991.
269.
Carabine UA, Milligan KR, Moore J: Extradural
clonidine and bupivacaine for postoperative analgesia. Br J Anaesth 68:132, 1992.
270.
Carabine UA, Milligan KR, Mulholland D, Moore
J: Extradural clonidine infusions for analgesia after total hip replacement. Br
J Anaesth 68:338, 1992.
271.
Rostaing S, Bonnet F, Levron JC: Effect of epidural
clonidine on analgesia and pharmacokinetics of epidural fentanyl in postoperative
patients. Anesthesiology 75:420, 1991.
272.
Bonnet F, Boico O, Rostaining S: Clonidine-induced
analgesia in postoperative patients: Epidural versus intramuscular administration.
Anesthesiology 72:423, 1990.
273.
Tryba M, Zenz M, Strumpf M: Clonidine i.v. is
equally effective as morphine i.v. for postoperative analgesia-A double blind study
[abstract]. Anesthesiology 75:A1085, 1991.
274.
DeKock M, Crochet B, Morimont C, Scholtes JL:
Intravenous or epidural clonidine for intra- and postoperative analgesia. Anesthesiology
79:525, 1993.
275.
Mogensen T, Eliasen K, Ejlersen E, et al: Epidural
clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine
and morphine regimen. Anesth Analg 75:607, 1992.
276.
Vercauteren M, Lauwers E, Meert T, et al: Comparison
of epidural sufentanil plus clonidine with sufentanil alone for postoperative pain
relief. Anaesthesia 45:531, 1990.
277.
Rockemann MG, Seeling W, Brinkmann A, et al:
Analgesic and hemodynamic effects of epidural clonidine, clonidine/morphine and morphine
after pancreatic surgery: A double-blind study. Anesth Analg 80:869, 1995.
278.
O'Meara ME, Gin T: Comparison of 0.125% bupivacaine
with 0.125% bupivacaine and clonidine as extradural analgesia in the first stage
of labour. Br J Anaesth 71:651, 1993.
279.
Brichant JF, Bonhomme V, Mikulski M, et al: Admixture
of clonidine to epidural bupivacaine for analgesia during labor: Effect of varying
clonidine doses [abstract]. Anesthesiology 81:A1136, 1994.
280.
Cigarini I, Kaba A, Bonnet F, et al: Epidural
clonidine combined with bupivacaine for analgesia in labor: Effects on mother and
neonate. Reg Anesth 20:113, 1995.
281.
Eisenach JC, DePen S, Dubois M, et al: Epidural
clonidine study group: Epidural clonidine anesthesia for intractable cancer pain.
Pain 61:391, 1995.
282.
Petros AJ, Wright RMB: Epidural and oral clonidine
in domiciliary control of deafferentation pain. Lancet 1:1034, 1987.
283.
Eisenach JC, Rauck RL, Buzzanell C, Lysak S:
Epidural clonidine analgesia for intractable cancer pain: Phase I. Anesthesiology
71:647, 1989.
284.
Ferit PA, Aydinli I, Akra S: Management of cancer
pain with epidural clonidine [abstract]. Reg Anesth 17(Suppl 3S):173, 1992.
285.
Lund C, Hansen O, Kehlet H: Effect of epidural
clonidine on somatosensory evoked potentials to dermatomal stimulation. Eur J Anaesth
6:207, 1989.
286.
Strube PJ, Lavies NG, Rubin J: Epidural clonidine
[letter]. Anaesthesia 39:834, 1984.
287.
Marruecos I, Roglan A, Frati ME, Artigas A: Clonidine
overdose. Crit Care Med 11:959, 1988.
288.
Zeigler D, Lynch SA, Muir J: Transdermal clonidine
versus placebo in painful diabetic neuropathy. Pain 48:403, 1992.
289.
Slogoff S: Perioperative ischemia. Semin Anesth
9:107, 1990.
290.
Quintin L, Viale JP, Annat G: Oxygen uptake after
major abdominal surgery: Effect of clonidine. Anesthesiology 74:236, 1991.
291.
Bailey PL, Sperry RJ, Johnson GK, et al: Respiratory
effects of clonidine alone and combined with morphine in humans. Anesthesiology
74:43, 1991.
292.
Ooi R, Pattison J, Feldman SA: The effects of
intravenous clonidine on ventilation. Anaesthesia 46:632, 1991.
293.
Rauck RL, Eisenach JC, Jackson K, et al: Epidural
clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology
79:1163, 1993.
294.
Uhde TW, Stein MB, Vittone BJ, et al: Behavioral
and physiologic effects of short-term and long-term administration of clonidine in
panic disorder. Arch Gen Psychiatry 46:170, 1989.
295.
Gold MS, Pottash AC, Sweeney DR, Klever HD: Opiate
withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment. JAMA
243:343, 1980.
296.
Franz DN, Hare BD, McCloskey KL: Spinal sympathetic
neurons: Possible sites of opiate-withdrawal suppression by clonidine. Science
215:1643, 1982.
297.
Davison R, Kaplan K, Fintel D, et al: The effect
of clonidine on the cessation of cigarette smoking. Clin Pharmacol Ther 44:265,
1988.
298.
Glassman AH, Stetner F, Walsh BT: Heavy smokers,
smoking cessation, and clonidine. Results of a double-blind, randomized trial.
JAMA 259:2863, 1988.
299.
Hughes JR: Clonidine, depression, and smoking
cessation. JAMA 259:2901, 1988.
300.
Metz SA, Halter JB, Robertson RP: Induction of
defective insulin secretion and impaired glucose tolerance by clonidine. Selective
stimulation of metabolic α-adrenergic pathways. Diabetes 27:554, 1978.
